TriaGen Wealth Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,264
Closed -$660K 172
2025
Q4
$660K Hold
5,264
0.17% 107
2025
Q3
$705K Buy
5,264
+3,599
+216% +$472K 0.18% 104
2025
Q2
$226K Buy
1,665
+118
+8% +$15.6K 0.07% 162
2025
Q1
$205K Buy
+1,547
New +$197K 0.07% 156
2024
Q1
Sell
-2,367
Closed -$261K 161
2023
Q4
$261K Hold
2,367
0.12% 136
2023
Q3
$229K Hold
2,367
0.12% 135
2023
Q2
$258K Sell
2,367
-47
-2% -$5.01K 0.12% 145
2023
Q1
$244K Buy
2,414
+21
+0.9% +$2.22K 0.12% 142
2022
Q4
$263K Buy
2,393
+8
+0.3% +$828 0.15% 143
2022
Q3
$231K Hold
2,385
0.13% 143
2022
Q2
$259K Buy
2,385
+18
+0.8% +$2.04K 0.18% 119
2022
Q1
$280K Hold
2,367
0.15% 145
2021
Q4
$333K Hold
2,367
0.16% 131
2021
Q3
$280K Hold
2,367
0.15% 151
2021
Q2
$286K Sell
2,367
-100
-4% -$11.7K 0.15% 153
2021
Q1
$296K Sell
2,467
-2,096
-46% -$248K 0.17% 134
2020
Q4
$500K Buy
+4,563
New +$496K 0.29% 95

Other funds holding ABT

TriaGen Wealth Management's ABT Position: Q1 2026 in Review

TriaGen Wealth Management sold out of Abbott (ABT) in Q1 2026, closing a stake of 5,264 shares — an estimated $660K sold.

TriaGen Wealth Management first reported a position in ABT in Q4 2020 and held it in 17 quarters. The position peaked at $705K in Q3 2025. 3,116 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • TriaGen Wealth Management reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • TriaGen Wealth Management sold 5,264 Abbott shares in Q1 2026, an estimated $660K.
  • TriaGen Wealth Management first reported a position in Abbott in Q4 2020 and held it in 17 quarters.
  • TriaGen Wealth Management's Abbott position peaked at $705K in Q3 2025.
  • 3,116 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on TriaGen Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.